Carpenter J, Johnson D, Wagner L, Andrykowski M: Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Nurs Forum. 2002, 29: E16-E25.
Article
Google Scholar
MacLennan A, Lester S, Moore V: Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric. 2001, 4: 58-74.
Article
CAS
PubMed
Google Scholar
Pritchard K, Khan H, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: The role of hormone replacement therapy in women with a previous diagnosis of breast cancer. CMAJ. 2002, 166: 1017-1022.
PubMed
PubMed Central
Google Scholar
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 without breast cancer. Lancet. 1997, 350: 1047-1059. 10.1016/S0140-6736(97)08233-0.
Article
Google Scholar
Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, et al: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003, 289: 3243-3253. 10.1001/jama.289.24.3243.
Article
CAS
PubMed
Google Scholar
Alving B: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase. NIH News. 2004, (last accessed 19 April 2005)., [http://www.nhlbi.nih.gov/new/press/04-03-02.htm]
Google Scholar
Col NF, Hirota LK, Orr RK, Erban JK, Wong JB, Lau J: Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk. J Clin Oncol. 2001, 19: 2357-2363.
CAS
PubMed
Google Scholar
Chlebowski R, Col N: Menopausal hormone therapy after breast cancer. Lancet. 2004, 363: 410-411. 10.1016/S0140-6736(04)15519-0.
Article
PubMed
Google Scholar
Holmberg L, Anderson H, for the HABITS steering and data monitoring committees: HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet. 2004, 363: 453-455. 10.1016/S0140-6736(04)15493-7.
Article
CAS
PubMed
Google Scholar
Eden JA, Wren BG: Hormone replacement therapy after breast cancer: a review. Cancer Treat Rev. 1996, 22: 335-343. 10.1016/S0305-7372(96)90006-7.
Article
CAS
PubMed
Google Scholar
Eden JA, Bush T, Nand S, Wren BG: A case–control study of combined continuous estrogen-progestin replacement therapy among women with a personal history of breast cancer. Menopause. 1995, 2: 67-72.
Article
Google Scholar
Dew J, Eden J, Beller E, Magarey C, Schwartz P, Crea P, Wren B: A cohort study of hormone replacement therapy given to women previously treated for breast cancer. Climacteric. 1998, 1: 137-142.
Article
CAS
PubMed
Google Scholar
Lau J: Metaanalyst. Boston, MA, USA
Vassilopoulou-Sellin R, Asmar L, Hortobagyi GN, Klein MJ, McNeese M, Singletary SE, Theriault RL: Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively. J Clin Oncol. 1999, 17: 1482-1487.
CAS
PubMed
Google Scholar
Beckmann MW, Jap D, Djahansouzi S, Nestle-Kramling C, Kuschel B, Dall P, Brumm C, Bender HG: Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates. Oncology. 2001, 60: 199-206. 10.1159/000055319.
Article
CAS
PubMed
Google Scholar
Durna EM, Crowe SM, Leader LR, Eden JA: Quality of life of breast cancer survivors: the impact of hormonal replacement therapy. Climacteric. 2002, 5: 266-276.
Article
CAS
PubMed
Google Scholar
Natrajan P, Soumakis K, Gambrell R: Estrogen replacement therapy in women with previous breast cancer. Am J Obstet Gynecol. 1999, 181: 288-295.
Article
CAS
PubMed
Google Scholar
Natrajan P, Gambrell R: Estrogen replacement therapy in patients with early breast cancer. Am J Obstet Gynecol. 2002, 187: 289-294. 10.1067/mob.2002.125999.
Article
CAS
PubMed
Google Scholar
Dew J, Wren B, Eden J: A cohort of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric. 2003, 6: 45-52.
Article
CAS
PubMed
Google Scholar
Marsden J, Whitehead M, A'Hern R, Baum M, Sacks N: Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?. Fertil Steril. 2000, 73: 292-299. 10.1016/S0015-0282(99)00510-5.
Article
CAS
PubMed
Google Scholar
Vassilopoulou-Sellin R, Cohen DS, Hortobagyi GN, Klein MJ, McNeese M, Singletary SE, Smith TL, Theriault RL: Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study. Cancer. 2002, 95: 1817-1826. 10.1002/cncr.10913.
Article
CAS
PubMed
Google Scholar
DiSaia P, Brewster W, Ziogas A, Anton-Culver H: Breast cancer survival and hormone replacement therapy: a cohort analysis. Am J Clin Oncol. 2000, 23: 541-545. 10.1097/00000421-200012000-00001.
Article
CAS
PubMed
Google Scholar
Durna E, Wren B, Heller G, Leader L, Sjoblom P, Eden J: Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality. Med J Aust. 2002, 177: 347-351.
PubMed
Google Scholar
Beckmann MW, Jap D, Djahansouzi S, Nestle-Kramling C, Kuschel B, Dall P, Brumm C, Bender HG: Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates. Oncology. 2001, 60: 199-206. 10.1159/000055319.
Article
CAS
PubMed
Google Scholar
Decker DA, Pettinga JE, VanderVelde N, Huang RR, Kestin L, Burdakin JH: Estrogen replacement therapy in breast cancer survivors: a matched-controlled series. Menopause. 2003, 10: 277-285. 10.1097/01.GME.0000061806.76067.E9.
Article
PubMed
Google Scholar
Marttunnen M, Hietanen P, Pyrhonen S, Tiitinen A, Ylikorkala O: A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy. Maturitas. 2001, 39: 217-225. 10.1016/S0378-5122(01)00211-0.
Article
Google Scholar
Ursic-Vrscaj M, Bebar S: A case-control study of hormone replacement therapy after primary surgical breast cancer treatment. Eur J Surg Oncol. 1999, 25: 146-151. 10.1053/ejso.1998.0617.
Article
CAS
PubMed
Google Scholar
Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG, Somerfield MR: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999, 17: 1080-1082.
CAS
PubMed
Google Scholar
Temple LK, Wang EE, McLeod RS: Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care. CMAJ. 1999, 161: 1001-1008.
CAS
PubMed
PubMed Central
Google Scholar
American Society of Clinical Oncology: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol. 1996, 14: 2843 -2877.
Google Scholar
Guthrie J, Dennerstein L, Hopper J, Burger H: Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol. 1996, 88: 437-442. 10.1016/0029-7844(96)00196-2.
Article
CAS
PubMed
Google Scholar
Overlie I, Moen M, Holte A, Finset A: Androgens and estrogens in relation to hot flashes during the menopausal transition. Maturitas. 2002, 41: 69-77. 10.1016/S0378-5122(01)00256-0.
Article
CAS
PubMed
Google Scholar
Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1999, 130: 270-277.
Article
CAS
PubMed
Google Scholar
Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002, 94: 606-616.
Article
Google Scholar
Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001/jama.288.3.321.
Article
Google Scholar
O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS: Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst. 2001, 93: 754-762. 10.1093/jnci/93.10.754.
Article
PubMed
Google Scholar